House File 2501 H-8487 Amend House File 2501 as follows: 1 1. Page 94, after line 10 by inserting: 2 < Sec. ___. Section 124E.2, subsection 2, paragraph i, Code 3 2018, is amended to read as follows: 4 i. Untreatable Chronic, severe, or untreatable pain. 5 Sec. ___. Section 124E.2, subsection 2, Code 2018, is 6 amended by adding the following new paragraphs: 7 NEW PARAGRAPH . j. Glaucoma. 8 NEW PARAGRAPH . k. Hepatitis C. 9 NEW PARAGRAPH . l. Ehlers-Danlos syndrome. 10 NEW PARAGRAPH . m. Post-traumatic stress disorder. 11 NEW PARAGRAPH . n. Tourette’s syndrome. 12 NEW PARAGRAPH . o. Muscular dystrophy. 13 NEW PARAGRAPH . p. Huntington’s disease. 14 NEW PARAGRAPH . q. Alzheimer’s disease. 15 NEW PARAGRAPH . r. Complex regional pain syndrome, types I 16 and II. 17 NEW PARAGRAPH . s. Rheumatoid arthritis. 18 NEW PARAGRAPH . t. Polyarteritis nodosa. 19 Sec. ___. Section 124E.2, subsection 6, Code 2018, is 20 amended to read as follows: 21 6. “Medical cannabidiol” means any pharmaceutical 22 grade cannabinoid found in the plant Cannabis sativa L. or 23 Cannabis indica or any other preparation thereof that has 24 a tetrahydrocannabinol level of no more than three percent 25 contains no more tetrahydrocannabinol than is medically 26 necessary for a ninety-day supply and that is delivered in a 27 form recommended by the medical cannabidiol board , approved by 28 the board of medicine, and adopted by the department pursuant 29 to rule. 30 Sec. ___. Section 124E.5, subsection 4, Code 2018, is 31 amended to read as follows: 32 4. Recommendations made by the medical cannabidiol board 33 pursuant to subsection 3 , paragraphs “b” and “e” , shall be made 34 to the board of medicine department for consideration, and if 35 -1- HF2501.5742 (1) 87 pf/rn 1/ 2 #1.

approved, shall be adopted by the board of medicine department 1 by rule. > 2 2. Page 95, after line 21 by inserting: 3 < Sec. ___. Section 124E.11, subsection 2, paragraph c, Code 4 2018, is amended to read as follows: 5 c. Establish the form and quantity of medical cannabidiol 6 allowed to be dispensed to a patient or primary caregiver 7 pursuant to this chapter as appropriate to serve the medical 8 needs of patients with debilitating medical conditions, subject 9 to recommendation by the medical cannabidiol board and approval 10 by the board of medicine . > 11 3. By renumbering as necessary. 12 ______________________________ FORBES of Polk -2- HF2501.5742 (1) 87 pf/rn 2/ 2 #2. #3.